09:55 AM EST - Zomedica Pharmaceuticals Corp. : Has entered into a license and supply agreement with Celsee, Inc., an innovator of progressive rare cell capture, characterization and retrieval products in the emerging field of liquid biopsy. Under the terms of the agreement, Zomedica will have animal health exclusive global rights to develop and market Celsee’s liquid biopsy platform for use by veterinarians as a cancer diagnostic. Zomedica Pharmaceuticals Corp.
shares V.ZOM are trading down $0.01 at $2.93.
